EUVIMEDEUVIMED entdecken
Open Access

Schisandrin A suppresses hepatocellular carcinoma and sensitizes to sorafenib via modulating retinol metabolism

Yu Zhou, Yufan Mao, Xueliang Fu, Yanan Li, Meng Xu, Deliang Zhou, Shuai Zha

American Journal of Cancer Research · 2026 · 16 (5) · 2040-2054

DOI: 10.62347/spol6693 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Cancer Research, 2026. Verfasst von Yu Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Laboratory Medicine, Hubei University of Chinese Medicine No. 16 Huangjiahu West Road, Hongshan District, Wuhan 430065, Hubei, PR China. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Hepatocellular carcinomaSchisandrin Acell cycle arrestretinol metabolismsorafenib

Autor:innen und Institutionen

  • School of Laboratory Medicine, Hubei University of Chinese Medicine No. 16 Huangjiahu West Road, Hongshan District, Wuhan 430065, Hubei, PR China.
  • Hubei Shizhen Laboratory No. 4 Huayuanshan, Wuchang District, Wuhan 430060, Hubei, PR China.
  • Research and Development Center of Science and Technology, Wuhan University No. 299 Bayi Road, Wuchang District, Wuhan 430072, Hubei, PR China.
  • School of Acupuncture-Moxibustion and Orthopedics, Hubei University of Chinese Medicine No. 188 Tanhualin, Wuchang District, Wuhan 430060, Hubei, PR China.
  • Department of Traditional Chinese Medicine, Maternal and Child Health Hospital of Hubei Province No. 745 Wuluo Road, Hongshan District, Wuhan 430070, Hubei, PR China.
  • Department of General Surgery, Affiliated Hospital of Hubei University of Chinese Medicine, Hubei Provincial Hospital of Traditional Chinese Medicine, Hubei Province Academy of Traditional Chinese Medicine No. 4 Huayuan…

Zitieren

APA

Zhou, Y., Mao, Y., Fu, X., Li, Y., Xu, M., Zhou, D., & Zha, S. (2026). Schisandrin A suppresses hepatocellular carcinoma and sensitizes to sorafenib via modulating retinol metabolism. American Journal of Cancer Research, 16(5), 2040-2054. https://doi.org/10.62347/spol6693

Vancouver

Zhou Y, Mao Y, Fu X, Li Y, Xu M, Zhou D, et al. Schisandrin A suppresses hepatocellular carcinoma and sensitizes to sorafenib via modulating retinol metabolism. American Journal of Cancer Research. 2026;16(5):2040-2054. doi:10.62347/spol6693

BibTeX
@article{Zhou2026,
  author = {Zhou, Yu and Mao, Yufan and Fu, Xueliang and Li, Yanan and Xu, Meng and Zhou, Deliang and Zha, Shuai},
  title = {Schisandrin A suppresses hepatocellular carcinoma and sensitizes to sorafenib via modulating retinol metabolism},
  journal = {American Journal of Cancer Research},
  year = {2026},
  volume = {16},
  number = {5},
  pages = {2040--2054},
  doi = {10.62347/spol6693}
}
Kostenlos starten →